Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Added 30 days ago (23.09.2021)
Authors: Wang, Y., Golesworthy, B., Cuggia, A., Domecq, C., Chaudhury, P., Barkun, J., Metrakos, P., Asselah, J., Bouganim, N., Gao, Z.-H., Chong, G., Foulkes, W. D., Zogopoulos, G.
Journal: JMG Online
Read article